In glioma patients, the accumulation of CD4+/CD8+ T cells and T regulatory cells (Tregs) that express high levels of CTLA-4 and PD-1, or the high expression of PD-L1 in glioma cells correlates with WHO high grade and short survival [53,54]. The gene discussed is PDCD1; the disease is central nervous system cancer.